Does AMLODIPINE Cause Hyperlactacidaemia? 105 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 105 reports of Hyperlactacidaemia have been filed in association with AMLODIPINE (Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide). This represents 0.2% of all adverse event reports for AMLODIPINE.
105
Reports of Hyperlactacidaemia with AMLODIPINE
0.2%
of all AMLODIPINE reports
20
Deaths
92
Hospitalizations
How Dangerous Is Hyperlactacidaemia From AMLODIPINE?
Of the 105 reports, 20 (19.0%) resulted in death, 92 (87.6%) required hospitalization, and 76 (72.4%) were considered life-threatening.
Is Hyperlactacidaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AMLODIPINE. However, 105 reports have been filed with the FAERS database.
What Other Side Effects Does AMLODIPINE Cause?
Hypotension (6,504)
Toxicity to various agents (5,554)
Completed suicide (5,267)
Drug ineffective (4,091)
Dyspnoea (3,907)
Dizziness (3,536)
Intentional overdose (3,427)
Fall (3,215)
Fatigue (3,141)
Headache (2,907)
What Other Drugs Cause Hyperlactacidaemia?
METFORMIN (807)
LINEZOLID (105)
ACETAMINOPHEN (96)
QUETIAPINE (68)
IBUPROFEN (55)
METHYLPREDNISOLONE (54)
LANSOPRAZOLE (52)
NOREPINEPHRINE (52)
MIRTAZAPINE (46)
LORAZEPAM (44)
Which AMLODIPINE Alternatives Have Lower Hyperlactacidaemia Risk?
AMLODIPINE vs AMLODIPINE BESILATE
AMLODIPINE vs AMLODIPINE\ATORVASTATIN
AMLODIPINE vs AMLODIPINE\BENAZEPRIL
AMLODIPINE vs AMLODIPINE\HYDROCHLOROTHIAZIDE\OLMESARTAN
AMLODIPINE vs AMLODIPINE\HYDROCHLOROTHIAZIDE\OLMESARTAN MEDOXOMIL